Spero Therapeutics, Inc. (SPRO)
1.215
0.00 (0.00%)
USD |
NASDAQ |
Aug 24, 16:00
1.21
0.00 (0.00%)
After-Hours: 20:00
Spero Therapeutics Price to Book Value : 1.598 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 1.598 |
| August 21, 2026 | 1.605 |
| August 20, 2026 | 1.592 |
| August 19, 2026 | 1.618 |
| August 18, 2026 | 1.578 |
| August 17, 2026 | 1.565 |
| August 14, 2026 | 1.618 |
| August 13, 2026 | 1.631 |
| August 12, 2026 | 1.565 |
| August 11, 2026 | 1.618 |
| August 10, 2026 | 1.618 |
| August 07, 2026 | 1.657 |
| August 06, 2026 | 1.671 |
| August 05, 2026 | 1.657 |
| August 04, 2026 | 1.618 |
| August 03, 2026 | 1.513 |
| July 31, 2026 | 1.539 |
| July 30, 2026 | 1.578 |
| July 29, 2026 | 1.565 |
| July 28, 2026 | 1.572 |
| July 27, 2026 | 1.552 |
| July 24, 2026 | 1.565 |
| July 23, 2026 | 1.526 |
| July 22, 2026 | 1.671 |
| July 21, 2026 | 1.815 |
| Date | Value |
|---|---|
| July 20, 2026 | 1.894 |
| July 17, 2026 | 2.078 |
| July 16, 2026 | 2.065 |
| July 15, 2026 | 2.236 |
| July 14, 2026 | 2.236 |
| July 13, 2026 | 2.868 |
| July 10, 2026 | 2.762 |
| July 09, 2026 | 2.789 |
| July 08, 2026 | 2.854 |
| July 07, 2026 | 2.841 |
| July 06, 2026 | 2.881 |
| July 02, 2026 | 2.894 |
| July 01, 2026 | 2.920 |
| June 30, 2026 | 2.907 |
| June 29, 2026 | 2.472 |
| June 26, 2026 | 2.472 |
| June 25, 2026 | 2.209 |
| June 24, 2026 | 2.297 |
| June 23, 2026 | 2.351 |
| June 22, 2026 | 2.417 |
| June 18, 2026 | 2.494 |
| June 17, 2026 | 2.308 |
| June 16, 2026 | 3.029 |
| June 15, 2026 | 3.182 |
| June 12, 2026 | 3.117 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Inovio Pharmaceuticals, Inc. | 23.55 |
| Fortress Biotech, Inc. | 0.5946 |
| Kura Oncology, Inc. | 22.78 |
| Legend Biotech Corp. | 3.300 |
| ACADIA Pharmaceuticals, Inc. | 3.906 |
Price to Book Value Related Metrics
| PE Ratio | 11.14 |
| PS Ratio | 1.632 |
| Price to Free Cash Flow | 3.582 |
| Price | 1.215 |
| Earnings Yield | 8.98% |
| Market Cap | 70.65M |
| Operating PE Ratio | 27.19 |
| Normalized PE Ratio | 10.43 |